UNSPSC 51143204: Acamprosate
Commodity
Code facts
- Part of
-
-
51000000
-
51140000
- 51143200
-
51140000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51143204
| NIGP code |
|---|
| 26912 Autonomic Drugs |
Definition
This classification denotes a neuroprotective agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N4K14YGM3J. European Medicines Agency schedules Acamprosate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07366MIG. Acamprosate generally arises in the molecular formula C5H11NO4S.
Read the full definition
The term ACAMPROSATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, no. 3 1990, list 30.) ACAMPROSATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule acamprosate under HS 29241900 and SITC 51471. As of Q4 2014, ACAMPROSATE remains the US FDA Preferred Term for this commodity. Acamprosate bears US NLM identifiers UMLS ID C0284941 and NCI Concept Code C81691. SMILES: S(=O)(=O)(O)CCCNC(=O)C.
About UNSPSC 51143204
UNSPSC 51143204 Acamprosate, a Commodity code, nominally represents a single pharmaceutical product — acamprosate calcium, used in alcohol-use-disorder treatment. However, the recent state and local procurement activity tagged under this code diverges sharply from that scope. Seminole County, Florida's June 2026 IFB (IFB60459723LAS) solicits naloxone and drug deactivation systems for community health support, neither of which is acamprosate. The code shows minimal direct alignment with its stated pharmaceutical commodity; the single recent opportunity reflects a misclassification or a county procurement system tagging error rather than genuine demand for acamprosate at the state and local level. State and local health departments, county community health offices, and special-purpose health districts would be the typical issuing bodies for acamprosate procurement, but the recent activity does not support active solicitation under this code.
The geographic and temporal data are insufficient to characterize meaningful activity. Seminole County's naloxone procurement (response deadline July 26, 2023, with a posted date of June 30, 2026 — a date inconsistency in the source itself) stands alone as a recent record. No other jurisdictions, states, or representative opportunities appear in the dataset. The mismatch between the code's pharmaceutical scope and the naloxone-focused solicitation suggests that this Commodity code does not currently reflect actionable state and local procurement opportunity; business development professionals should verify whether acamprosate appears in other procurement channels or track this code for future reclassification or corrected tagging by issuing bodies.
Quick answers
What is UNSPSC 51143204?
UNSPSC 51143204 is Acamprosate, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51143204?
UNSPSC 51143204 maps to 1 NIGP code, 26912 Autonomic Drugs.
On GovTribe
See everything under UNSPSC 51143204
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code